Equitable Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Equitable Trust's XBI Position: Q4 2024 in Review
Equitable Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 2,138 shares — an estimated $211K sold.
Equitable Trust first reported a position in XBI in Q2 2018 and held it in 21 quarters. The position peaked at $9.73M in Q1 2022. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.
- Equitable Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
- Equitable Trust sold 2,138 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $211K.
- Equitable Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 21 quarters.
- Equitable Trust's State Street SPDR S&P Biotech ETF position peaked at $9.73M in Q1 2022.
- 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.
Based on Equitable Trust's 13F filing for Q4 2024, filed 28 Jan 2025.